Closing the tau loop: The missing tau mutation

Brain

Volumn 138, Issue 10, 2015, Pages 3100-3109

  McCarthy, Allan ^a   Lonergan, Roisin ^a   Olszewska, Diana A ^a   O'Dowd, Sean ^a   Cummins, Gemma ^b   Magennis, Brian ^a   Fallon, Emer M ^a   Pender, Niall ^c,j   Huey, Edward D ^d   Cosentino, Stephanie ^e   O'Rourke, Killian ^a   Kelly, Brendan D ^a   O'Connell, Martin ^a   Delon, Isabelle ^f   Farrell, Michael ^c   Spillantini, Maria Grazia ^g   Rowland, Lewis P ^h   Fahn, Stanley ^h   Craig, Peter ⁱ   Hutton, Michael ⁱ   Lynch, Tim ^a   more..

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c BEAUMONT HOSPITAL   (Ireland)

^d University Medical Centre ^*  (United States)

^e NewYork Presbyterian Hospital   (United States)

^f ADDENBROOKE S HOSPITAL   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ ELI LILLY AND COMPANY   (United States)

^j ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

more..

Author keywords

dementia; frontotemporal; FTDP 17; MAPT; stem loop

Indexed keywords

CITALOPRAM; DONEPEZIL; ESCITALOPRAM; RNA; SERTRALINE; TAU PROTEIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; AMNESIA; ANXIETY DISORDER; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR DISORDER; BLUNTED AFFECT; BRONCHOPNEUMONIA; CHROMOSOME 17; DEPRESSION; EXON; FAMILY STUDY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MALE; MONTREAL COGNITIVE ASSESSMENT; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; OBSESSIVE COMPULSIVE DISORDER; PARKINSONISM; PEDIGREE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEGREGATION ANALYSIS; SHUFFLING GAIT; SIBLING; YOUNG ADULT; BRAIN; CASE REPORT; FAMILY HEALTH; GENETICS; MIDDLE AGED; MISSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

BRAIN; FAMILY HEALTH; FLUORODEOXYGLUCOSE F18; FRONTOTEMPORAL DEMENTIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION, MISSENSE; POSITRON-EMISSION TOMOGRAPHY; TAU PROTEINS;

EID: 84952897418     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv234     Document Type: Article

References (44)

1. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature, 2006 442 916-19.
2. Borroni B, Archetti S, Alberici A, Agosti C, Gennarelli M, Bigni B, et al. Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series. Neurogenetics 2008; 9: 197-205.
3. Costa S, Sua rez-Calvet M, Anton S, Dols-Icardo O, Clarimon J, Alcolea D, et al. Comparison of 2 diagnostic criteria for the behavioral variant of frontotemporal dementia. Am J Alzheimers Dis Other Demen 2013; 28: 469-76.
4. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006; 442: 920-4.
5. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011; 72: 245-56.
6. Dawson HN, Cantillana V, Chen L, Vitek MP. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model. J Neurosci 2007; 27: 9155-68.
7. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimers disease. Neuron 1989; 3: 519-26.
8. Goedert M, Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J 1990; 9: 4225-30.
9. Goedert M, Jakes R. Mutations causing neurodegenerative tauopathies. Biochem Biophys Acta 2005; 1739: 240-50.
10. Grover A, Houlden H, Baker M, Adamson J, Lewis J, Prihar G, et al. 5 splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J Biol Chem 1999; 274: 15134-43.
11. Hasegawa M, Smith MJ, Goedert M. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett 1998; 437: 207-10.
12. Hutton M. Missing tau mutation identified. Ann Neurol 2000; 47: 417-18.
13. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702-5.
14. Iijima M, Tabira T, Poorkaj P, Schellenberg GD, Trojanowski JQ, Lee VM, et al. A distinct familial presenile dementia with a novel missense mutation in the tau gene. Neuroreport 1999; 10: 497-501.
15. Kar A, Fushimi K, Zhou X, Ray P, Shi C, Chen X et al. RNA Helicase p68 (DDX5) Regulates tau Exon 10 Splicing by Modulating a Stem-Loop Structure at the 5 Splice Site. Mol Cell Biol 2011; 31: 1812-21.
16. Kowalska A, Hasegawa M, Miyamoto K, Akiguchi I, Ikemoto A, Takahashi K, et al. A novel mutation at position + 11 in the intron following exon 10 of the tau gene in FTDP-17. J Appl Genet 2002; 43: 535-43.
17. Lantos PL, Cairns NJ, Khan MN, King A, Revesz T, Janssen JC, et al., Neuropathologic variation in frontotemporal dementia due to the intronic tau 10( + 16) mutation. Neurology 2002; 58: 1169-75.
18. Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia- parkinsonism-amyotrophy complex. Neurology 1994; 44: 1878-84.
19. Magnani E, Fan J, Gasparini L, Golding M, Williams M, Schiavo G, et al.: Interaction between tau and the dynactin complex. EMBO J 2007; 26: 4546-54.
20. Miyamoto K, Kowalska A, Hasegawa M, Tabira T, Takahashi K, Araki W et al., Familial frontotemporal dementia and parkinsonism with a novel mutation at an intron 10 + 11-splice site in the tau gene. Ann Neurol 2001; 50: 117-120.
21. Morfini GA1, Burns M, Binder LI, Kanaan NM, LaPointe N, Bosco DA, et al. Axonal transport defects in neurodegenerative diseases. J Neurosci 2009; 29: 12776-86.
22. Murray B, Lynch T, Farrell M. Clinicopathological features of the tauopathies. Biochem Soc Trans 2005; 33(Pt 4): 595-9.
23. Nacharaju P, Lewis J, Easson C, Yen S, Hackett J, Hutton M, et al. Accelerated filament formation from tau protein with specific FTDP- 17 missense mutations. FEBS Lett 1999; 447: 195-9.
24. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-54.
25. ODowd ST, Ardah MT, Johansson P, Lomakin A, Benedek GB, Roberts KA, et al. The ELISA-measured increase in cerebrospinal fluid tau that discriminates Alzheimers disease from other neurodegenerative disorders is not attributable to differential recognition of tau assembly forms. J Alzheimers Dis 2013; 33: 923-8.
26. Onyike CU, Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int Rev Psychiatry Abingdon Engl 2013; 25: 130-7. [cited 2014 Jun 20]
27. Pickering-Brown SM, Richardson AM, Snowden JS, McDonagh AM, Burns A, Braude W et al., Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain 2002; 125(Pt 4): 732-51.
28. Porta S, Kwong LK, Trojanowski JQ, Lee VM. Drosha inclusions are new components of dipeptide-repeat protein aggregates in FTLDTDP and ALS C9orf72 expansion cases. J Neuropathol Exp Neurol 2015; 74: 380-7.
29. Qian W, Liu F. Regulation of alternative splicing of tau exon 10. Neurosci Bull 2014; 30: 367-77.
30. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain J Neurol 2011; 134(Pt 9): 2456-77.
31. Renton AE, Majounie E, Waite A, Simo n-Sanchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS -FTD. Neuron 2011; 72: 257-68.
32. Rippon GA, Crook R, Baker M, Halvorsen E, Chin S, Hutton M, et al. Presenilin 1 mutation in an african american family presenting with atypical Alzheimer dementia. Arch Neurol 2003; 60: 884-8.
33. Rizzu P, Van Swieten JC, Joosse M, Hasegawa M, Stevens M, Tibben A et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet 1999; 64: 414-21.
34. Rohrer JD, Warren JD. Phenotypic signatures of genetic frontotemporal dementia. Curr Opin Neurol 2011; 24: 542-9.
35. Sima AA, Defendini R, Keohane C, DAmato C, Foster NL, Parchi P, et al. The neuropathology of chromosome 17-linked dementia. Ann Neurol 1996; 39: 734-43.
36. Spillantini MG, Goedert M, Tau pathology and neurodegeneration, Lancet Neurol 2013; 6: 609-22.
37. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998; 95: 7737-41.
38. Stanford PM, Halliday GM, Brooks WS, Kwok JB, Storey CE, Creasey H, et al. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. Brain J Neurol 2000; 123 (Pt 5): 880-93.
39. Umeda T, Yamashita T, Kimura T, Ohnishi K, Takuma H, Ozeki T, et al. Neurodegenerative disorder FTDP-17-related tau intron 10 + 16C ! T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice. Am J Pathol 2013; 183: 211-25.
40. Varani L, Spillantini MG, Goedert M, Varani G, Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by amynoglycoside antibiotics. Nucleic Acids Res 2000; 28: 710-19
41. Wang J-Z, Liu F. Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol 2008; 85: 148-75.
42. Wilhelmsen KC, Lynch T, Pavlou E, Higgins M, Nygaard TG. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet 1994; 55: 1159-65.
43. Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus- Hernandez M, et al. Neuroimaging signatures of frontotemporal dementia genetics:C9ORF72, tau, progranulin and sporadics. Brain 2012; 135: 794-806.
44. Yasuda M, Takamatsu J, DSouza I, Crowther RA, Kawamata T, Hasegawa M, et al. A novel mutation at position + 12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto). Ann Neurol 2000; 47: 422-9.